WO2005070398A3 - Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents - Google Patents
Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents Download PDFInfo
- Publication number
- WO2005070398A3 WO2005070398A3 PCT/IB2005/000156 IB2005000156W WO2005070398A3 WO 2005070398 A3 WO2005070398 A3 WO 2005070398A3 IB 2005000156 W IB2005000156 W IB 2005000156W WO 2005070398 A3 WO2005070398 A3 WO 2005070398A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solvents
- pharmaceutical compositions
- stabilized
- candesartan cilexetil
- cilexetil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN127/DEL/2004 | 2004-01-23 | ||
IN127DE2004 | 2004-01-23 | ||
IN1506/DEL/2004 | 2004-08-16 | ||
IN1506DE2004 | 2004-08-16 | ||
IN2402/DEL/2004 | 2004-12-01 | ||
IN2402DE2004 | 2004-12-01 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2005070398A2 WO2005070398A2 (en) | 2005-08-04 |
WO2005070398A3 true WO2005070398A3 (en) | 2006-03-30 |
WO2005070398A8 WO2005070398A8 (en) | 2006-05-04 |
Family
ID=34811697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/000156 WO2005070398A2 (en) | 2004-01-23 | 2005-01-21 | Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005070398A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010502698A (en) * | 2006-09-05 | 2010-01-28 | アストラゼネカ アクチボラグ | Pharmaceutical composition comprising candesartan cilexetil |
WO2008045006A1 (en) * | 2006-10-11 | 2008-04-17 | Fako Ilaclari A. S. | Formulations of candesartan |
WO2008065097A2 (en) * | 2006-11-28 | 2008-06-05 | Laboratorios Liconsa, S.A. | Stabilized solid pharmaceutical composition of candesartan cilexetil |
WO2008068727A2 (en) * | 2006-12-06 | 2008-06-12 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising candesartan cilexetil |
WO2008084504A2 (en) * | 2007-01-12 | 2008-07-17 | Rubicon Research Private Limited | Pharmaceutical compositions of angiotensin ii receptor blockers |
EP1952806A1 (en) | 2007-02-01 | 2008-08-06 | Helm AG | Process for the preparation of adsorbates of candesartan |
PL384680A1 (en) * | 2007-03-28 | 2008-09-29 | Zak & Lstrok Ady Farmaceutyczn | Pharmaceutical composition containing cylexyethyl candesarthan and its production method |
WO2009017812A2 (en) * | 2007-08-01 | 2009-02-05 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition of candesartan |
DE102007052070A1 (en) | 2007-10-30 | 2009-05-07 | Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg | candesartancilexetil |
SI2165702T1 (en) | 2008-09-17 | 2012-05-31 | Helm Ag | Stable and readily dissolved compositions of candesartan cilexetil prepared with wet granulation |
DE102008059206A1 (en) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic |
ES2364011B1 (en) | 2009-11-20 | 2013-01-24 | Gp Pharm, S.A. | CAPSULES OF PHARMACEUTICAL ACTIVE AND ESTERS OF POLYINSATURATED FATTY ACIDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES. |
JP2013067574A (en) * | 2011-09-21 | 2013-04-18 | Teva Pharma Japan Inc | Stabilized pharmaceutical composition |
CN104507459A (en) | 2012-05-07 | 2015-04-08 | 拜耳制药股份公司 | Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil |
CN117442577B (en) * | 2023-12-21 | 2024-03-15 | 山东则正医药技术有限公司 | Candesartan cilexetil microchip and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0546358A2 (en) * | 1991-11-20 | 1993-06-16 | Takeda Chemical Industries, Ltd. | Pharmaceutical compositions with angiotensin-II-antagonistic activity |
WO1997037688A2 (en) * | 1996-04-05 | 1997-10-16 | Takeda Chemical Industries, Ltd. | Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
US6299904B1 (en) * | 1997-05-27 | 2001-10-09 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation |
-
2005
- 2005-01-21 WO PCT/IB2005/000156 patent/WO2005070398A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0546358A2 (en) * | 1991-11-20 | 1993-06-16 | Takeda Chemical Industries, Ltd. | Pharmaceutical compositions with angiotensin-II-antagonistic activity |
WO1997037688A2 (en) * | 1996-04-05 | 1997-10-16 | Takeda Chemical Industries, Ltd. | Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
US6299904B1 (en) * | 1997-05-27 | 2001-10-09 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation |
Also Published As
Publication number | Publication date |
---|---|
WO2005070398A2 (en) | 2005-08-04 |
WO2005070398A8 (en) | 2006-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005070398A8 (en) | Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents | |
IL191043A0 (en) | Aminopyrimidine derivatives and pharmaceutical compositions containing the same | |
WO2007109604A3 (en) | Pharmaceutical compositions | |
WO2008011392A8 (en) | Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation | |
IL189782A (en) | Sulphonylpyrrole derivatives and pharmaceutical compositions containing the same and uses thereof | |
MX286273B (en) | Compositions and methods for inhibition of the jak pathway. | |
IL189697A0 (en) | Pyridazinone derivatives and pharmaceutical compositions containing the same | |
IL188941A0 (en) | Pyrazinolyguanidine derivatives and pharmaceutical compositions containing the same | |
WO2006102610A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
IL186738A0 (en) | Pyrizole derivatives and pharmaceutical compositions containing the same | |
IL195488A (en) | Compounds, pharmaceutical compositions comprising the same and uses thereof | |
WO2005079751A3 (en) | Oral pharmaceutical compositions of candesartan cilexetil | |
WO2005123076A3 (en) | Pharmaceutical compositions | |
IL196601A0 (en) | Pyrimidine derivatives and pharmaceutical compositions containing the same | |
IL183919A0 (en) | Triazolophthalazine derivatives and pharmaceutical compositions containing the same | |
IL183583A0 (en) | Quinazoline derivatives and pharmaceutical compositions containing the same | |
IL196033A0 (en) | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
WO2005097825A3 (en) | Bmp-7 variants with improved properties | |
IL177496A0 (en) | Amido-substituted hydroxy -6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same | |
WO2007106436A3 (en) | Photoactive compounds and compositions and uses thereof | |
WO2006128143A3 (en) | Hydantoin compounds | |
WO2007025146A3 (en) | Balsalazide formulations and manufacture and use thereof | |
WO2008054808A3 (en) | Elvucitabine pharmaceutical compositions | |
WO2006097617A3 (en) | Novel dihydropyrimidine derivatives and their use as anti-cancer agents | |
IL184996A0 (en) | Dihydroimidazothiazole derivatives and pharmaceutical compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WR | Later publication of a revised version of an international search report | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |